November is well known around the world as the official month of recognition and prevention of prostate cancer, and the Blue November campaign strengthens the risk of disease and interest in everyday testing.
According to the ministry of health, prostate cancer ranked second in the ranking of the most common diseases in men behind skin cancer.
In addition to testing and recommended treatment, maintaining regular sleep can help fight this type of cancer.
Melatonin, also known as sleep-regulating hormone, has the potential to delay tumor growth. This substance controls the formation of new blood vessels in the already existing vascular system of the tumor called angiogenesis.
According to Duraflex sleep consultant Renata Federighi, melatonin is naturally produced because of the lack of lighting to play a role in informing the body at bedtime. "It is important that if people sleep without interfering with the light, they harm their health without interfering with their production," he explains.
During the night, cells must be completely rested to avoid mutations without losing efficiency. Mutations can cause cancer. "Taking sleep for several hours weakens the immune system and promotes inflammation, making the body more vulnerable to tumors," Renata added.
Harvard on prostate cancer
According to a study conducted by Harvard University in the United States, a satisfactory level of melatonin can reduce the risk of prostate cancer. They were assessed for the probability of developing a disease that was found to be 92% male, 75% lower in people with high levels of hormones.
Experts provide advice on the right treatment of quality sleep and body functions. "It's important to pay attention to your posture. It's important to use pillows that provide comfort and head restraints, align your spine, keep it as quiet and dark as possible, keep the environment cool, stay healthy and avoid irritating activities before sleep. " Duoflex dream consultant concludes.